CUA guidelines on prostate biopsy methodology

Journal of the Canadian Urological Association

Volumn 4, Issue 2, 2010, Pages 89-94

  El Hakim, Assaad ^a   Moussa, Sabri ^b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951186191     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.10021     Document Type: Article

References (76)

1. Lee G, Attar K, Laniado M, et al. Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 2007;39:185-8.
2. Maan Z, Cutting CW, Patel U, et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int 2003;91:798-800.
3. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound-guided prostate needle biopsy: a prospective study and review of the literature. J Urol 1998;160:2115-20.
4. Herget EJ, Saliken JC, Donnelly BJ, et al. Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can Assoc Radiol J 1999;50:173-6.
5. Connor SE, Wingate JP. Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy: a survey of current practice amongst radiologists and urologists. Clin Radiol 1999;54:598-603.
6. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506-11.
7. Ihezue CU, Smart J, Dewbury KC, et al. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 2005;60:459-63.
8. Shandera KC, Thibault GP, Deshon GE Jr. Variability in patient preparation for prostate biopsy among American urologists. Urology 1998;52:644-6.
9. Davis M, Sofer M, Kim SS, et al. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 2002;167:566-70.
10. Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 2000;164:76-80.
11. Aus G, Ahlgren G, Bergdahl S, et al. Infection after transrectal core biopsies of the prostate-risk fac-tors and antibiotic prophylaxis. Br J Urol 1996;77:851-5.
12. Collins GN, Lloyd SN, Hehir M, et al. Multiple transrectal ultrasound-guided prostatic biopsies-true morbidity and patient acceptance. Br J Urol 1993;71:460-3.
13. Djavan B, Waldert M, Zlotta A, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166:856-60.
14. Kapoor DA, Klimberg IW, Malek GH, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552-8.
15. Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002;60:826-30.
16. Ramey JR, Halpern EJ, Gomlla LG. Ultrasonography and Biopsy of the Prostate. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, PA: Saunders; 2002:2883-95.
17. Sabbagh R, McCormack M, Peloquin F, et al. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol 2004;11:2216-9.
18. Tal R, Livne PM, Lask DM, et al. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 2003;169:1762-5.
19. Shigehara K, Miyagi T, Nakashima T, et al. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 2008;14:40-3.
20. Clements R, Aideyan OU, Griffiths GJ, et al. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 1993;47:125-6.
21. Nash PA, Bruce JE, Indudhara R, et al. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol 1996;155:607-9.
22. Cevik I, Ozveri H, Dillioglugil O, et al. Lack of effect of intrarectal lidocaine for pain control during transrectal prostate biopsy: a randomized prospective study. Eur Urol 2002;42:217-20.
23. Trucchi A, De Nunzio C, Mariani S, et al. Local anesthesia reduces pain associated with transrectal prostatic biopsy. A prospective randomized study. Urol Int 2005;74:209-13.
24. Lynn NN, Collins GN, Brown SC, et al. Periprostatic nerve block gives better analgesia for prostatic biopsy. BJU Int 2002;90:424-6.
25. Alavi AS, Soloway MS, Vaidya A, et al. Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods. J Urol 2001;166:1343-5.
26. Obek C, Onal B, Ozkan B, et al. Is periprostatic local anesthesia for transrectal ultrasound guided prostate biopsy associated with increased infectious or hemorrhagic complications? A prospective randomized trial. J Urol 2002;168:558-61.
27. Conde Redondo C, Alonso Fernández D, Robles Samaniego A, et al. TRUS-guided biopsy: comparison of two anesthetic methods [in Spanish]. Actas Urol Esp 2006;30:134-8.
28. Bhomi KK, Lim HH, Consigliere DT, et al. Control of pain during transrectal ultrasound-guided prostate biopsy: a prospective study comparing two methods. Urol Int 2007;79:332-5.
29. Haq A, Patel HR, Habib MR, et al. Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate: a double-blind, randomized controlled trial. J Urol 2004;171:1489-91.
30. Irer B, Gulcu A, Aslan G, et al. Diclofenac suppository administration in conjunction with lidocaine gel during transrectal ultrasoundguided prostate biopsy: prospective, randomized, placebo-controlled study. Urology 2005;66:799-802.
31. Rogatsch H, Moser P, Volgger H, et al. Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens. Hum Pathol 2000;31:1102-7.
32. Kao J, Upton M, Zhang P, et al. Individual prostate biopsy core embedding facilitates maximal tissue representation. J Urol 2002;168:496-9.
33. Terris MK. Ultrasonography and Biopsy of the Prostate. In: Walsh, P. C., Retik AB, Vaughan ED, Wein AJ, Kavoussi LR, Novick AC, eds. Campbell's Urology. 8th ed. Pennsylvania, PA: WB Saunders; 2002:3054.
34. Taneja SS, Penson DF, Epelbaum A, et al. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen. J Urol 1999;162:1352-7.
35. Gupta C, Ren JZ, Wojno KJ. Individual submission and embedding of prostate biopsies decreases rates of equivocal pathology reports. Urology 2004;63:83-6.
36. Kaye KW. Prostate biopsy using automatic gun. Technique for determination of precise biopsy site. Urology 1989;34:111-2.
37. Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002;167:1648-52.
38. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4.
39. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-202.
40. Presti JC Jr, Chang JJ, Bhargava V, et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000;163:163-6.
41. Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997;50:562-6.
42. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995;45:2-12.
43. Fink KG, Hutarew G, Pytel A, et al. One 10-core prostate biopsy is superior to two sets of sextant prostate biopsies. BJU Int 2003;92:385-8.
44. Durkan GC, Sheikh N, Johnson P, et al. Improving prostate cancer detection with an extended-core transrectal ultrasonographyguided prostate biopsy protocol. BJU Int 2002;89:33-9.
45. Brossner C, Bayer G, Madersbacher S, et al. Twelve prostate biopsies detect significant cancer volumes (> 0.5 mL). BJU Int 2000;85:705-7.
46. Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163:152-7.
47. Chang JJ, Shinohara K, Bhargava V, et al. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998;160:2111-4.
48. Eichler K, Hempel S, Wilby J, et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175:1605-12.
49. Pepe P, Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 2007;70:1131-5.
50. Toi A, Neill MG, Lockwood GA, et al. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007;177:516-20.
51. Applewhite JC, Matlaga BR, McCullough DL, et al. Transrectal ultrasound and biopsy in the early diagnosis of prostate cancer. Cancer Control 2001;8:141-50.
52. Uzzo RG, Wei JT, Waldbaum RS, et al. The influence of prostate size on cancer detection. Urology 1995;46:831-6.
53. Levine MA, Ittman M, Melamed J, et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998;159:471-5.
54. Karakiewicz PI, Bazinet M, Aprikian AG, et al. Outcome of sextant biopsy according to gland volume. Urology 1997;49:55-9.
55. Applewhite JC, Metwalli AR, McCullough DL. Results of the five-region prostate biopsy method: the effect of gland size and number of cores on yield. Proceedings of the 64th Annual Meeting of the Southeastern Section of the American Urological Association; March 30 - April 2, 2000; Orlando, FL.
56. Remzi M, Fong YK, Dobrovits M, et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 2005;174:1256-60.
57. Epstein JI, Walsh PC, Sauvageot J, et al. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol 1997;158:1886-90.
58. Terris MK, Pham TQ, Issa MM, et al. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 1997;157:204-6.
59. Fleshner NE, Fair WR. Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 1997;157:556-8.
60. Bazinet M, Karakiewicz PI, Aprikian AG, et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol 1996;155:605-6.
61. Hong YM, Lai FC, Chon CH, et al. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol 2004;22:7-10.
62. Haussler O, Epstein JI, Amin MB, et al. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neopla-sia, and cancer. Hum Pathol 1999;30:1077-86.
63. O'dowd GJ, Miller MC, Orozco R, et al. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000;55:553-9.
64. Shepherd D, Keetch DW, Humphrey PA, et al. Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol 1996;156:460-2.
65. Allen EA, Kahane H, Epstein JI. Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology 1998;52:803-7.
66. Park S, Shinohara K, Grossfeld GD, et al. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 2001;165:1409-14.
67. Kronz JD, Shaikh AA, Epstein JI. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Hum Pathol 2001;32:389-95.
68. Lefkowitz GK, Sidhu GS, Torre P, et al. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology 2001;58:999-1003.
69. Mian BM, Naya Y, Okihara K, et al. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 2002;60:836-40.
70. Moore CK, Karikehalli S, Nazeer T, et al. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005;173:70-2.
71. Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993;24:819-32.
72. Amin M, Jeyaganth S, Fahmy N, et al. Subsequent prostate cancer detection in patients with prostatic intraepithelial noeplasia or atypical small acinar proliferation. Can Urol Assoc J 2007;1:245-9.
73. Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol 1997;21:1489-95.
74. Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166:86-91.
75. Borboroglu PG, Comer SW, Riffenburgh RH, et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000;163:158-62.
76. Igel TC, Knight MK, Young PR, et al. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J Urol 2001;165:1575-9.